The Board of Directors of Cohance Lifesciences Limited will meet on November 12, 2025, to consider and approve the unaudited financial results for the quarter and half-year ending September 30, 2025. The trading window for dealing in the company’s securities will be closed from October 1, 2025, to November 14, 2025.
Board Meeting Announcement
Cohance Lifesciences Limited announced that a meeting of its Board of Directors is scheduled for November 12, 2025. The primary agenda of the meeting is to review and approve the unaudited financial results. This review will cover the company’s performance for both the quarter and the half-year period concluding on September 30, 2025.
Trading Window Closure
In line with regulatory requirements for the prevention of insider trading, Cohance Lifesciences Limited has announced the closure of its trading window. The period during which company insiders are restricted from trading in the company’s shares will commence on October 01, 2025, and will remain in effect until November 14, 2025. This includes both dates.
Source: BSE
